In my role as Director of Evidence at MSI Reproductive Choices (MSI), I managed a team of 15 analysts, reserachers and HMIS advisors supporting evidence generation and data-driven programming across MSI's 37 country programmes. I also oversaw a portfolio of formative, operational and clinical research projects. Studies or data analytics covered a wide range of themes, including self-care/pharmacy provision, adolescent SRH, quality improvement, health financing, task-sharing, coverage and reach to marginalised or vulnerable groups, and introduction of new SRH technologies. We also focused on evidence dissemination, and among other initiatives I managed the development of MSI's SafeAccess hub for abortion evidence. I also managed our HMIS team, who implemented front-line data collection systems, and developed tools to enable data-driven decision-making. I was also MSI's Learning lead on th 22-country FCDO Women's Integrated Sexual Health (WISH) programme.   

In my previous roles at LSHTM, I conducted research for the ALPHA network, analysing HIV policies and their implementation in services access across 6 sub-Saharan countries; and for the Integra Initiative, a multi-country study investigating the integration of SRH and HIV services, and a partnership between LSHTM, Population Council and the International Planned Parenthood Federation. My PhD, which formed one sub-study within Integra, was an in-depth case study comparing four different models of HIV care and treatment (stand-alone and integrated SRH-HIV services) in Swaziland. Areas of focus were contraceptive needs and practices among people living with HIV, use of integrated services, satisfaction with care, and perceptions of HIV-related stigma. The study utilised mixed quantitative and qualitative methodologies.